Speckulator will probably post this in a prettier format,

New Post Public Reply Private Reply Replies (1) Message Board
STEEL PENNY
355
Speckulator will probably post this in a prettier format, but if you don't subscribe to the HannoverHouseMovies.blogspot.com, you really should. I read this today and decided to buy a few more shares. You might want to consider doing the same before Eric and Fred decide it's time to take a bite.

Two of the great things that happen when they buy - their sales are restricted and they have to file a Form 4 telling the world they are acquiring. In my opinion, it's all good and I/we can look forward to being rewarded. But, I should also tell you, I've been wrong before. So don't invest what you can't afford to lose.

Ok HHSE, let's ride.




HHSE Investor Relations

Welcome to the Hannover House Investor Relations Blog
Thursday, June 14, 2018


Securities Attorney Opinion: It is legal for HHSE officers to BUY shares on open market
Greetings HHSE Friends & Followers - A combination of factors have created an environment within which the stock pricing for HHSE has been temporarily and artificially lowered through manipulative trading activities.

Due to the current, absurdly low stock price, HHSE managers reached out this morning to a securities attorney to seek an opinion as to whether it was LEGAL and APPROPRIATE for Parkinson and / or Shefte to PURCHASE HHSE shares off the open market in order to achieve a substantial R.O.I. benefit for their trusts.

Here's a summary of the securities attorney's opinion:

1). Yes, public company officers are allowed to buy shares on the open market, but these shares immediately become "restricted" from regular resale, as with all other officer owned or controlled Rule 144 shares.

2). Yes, but if a public company officer buys any shares, these acquisitions or dispositions must be disclosed in a Form 4 filing with the S.E.C. "...before the end of the second business day following the day on which a transaction resulting in a change in beneficial ownership has been executed."

3). Yes, public company officers can profit from buying shares during artificially manipulated pricing dips, but not if the officers have any involvement with the traders or brokers that have created the artificially low pricing.

4). Yes, public company officers CAN act on their superior knowledge of a company's operations and activities and make wise investment decisions... PROVIDED... that all of the key elements for motivating an officer's direct purchase of shares are based on publicly disclosed information... in order that no non-affiliate shareholders are impeded from having the same, superior and accurate information about the company.

ACCORDINGLY, and in order to be fully transparent in providing ALL SHAREHOLDERS with the same level of superior, accurate and updated information on all activities for HHSE that is enjoyed by the managers, please note the following key updates:


1). FORM 10 REGISTRATION activities are well into motion. HHSE managers believe that the fully reporting status (automatic on 60-days after filing), will positively impact the company's share price and volume.

2). MAJOR INSTITUTIONAL INVESTORS / FUNDS - HHSE managers have been working with three major investors / fund groups, one of which has already accumulated a position in HHSE. The other two are restricted from acquiring Pinksheet equities, but have confirmed with HHSE their intentions to acquire significant shares "post registration." HHSE managers believe that the successful recruitment of these major funds into HHSE will have a very significant and positive impact to the share price, volume and liquidity.

3). ELIMINATION OF BALANCE SHEET DEBTS - As a component of the Registration filing, HHSE managers have successfully negotiated substantial reductions in debts currently carried on the Balance Sheet (which have been achieved without any new share issuances). HHSE managers feel that this will improve the optics of the company's liquidity and credibility to outside financiers.

4). ELIMINATION OF NUISANCE LEGAL MATTERS - The evolution and maturation of the home video business (away from Physical unit sales to streaming), has resulted in some dead-on-arrival DVD releases for HHSE over the past few years... and this has ended up in "nuisance" lawsuits from small producers that have ignored the contractual structure and disputed the applicability of releasing costs. One recent case, AMITYVILLE ASYLUM, was found in HHSE's favor, and another recent case (XVIII ENTERTAINMENT - four titles), was dismissed. There are other cases in motion, including Origin Films and Crimson Forest, that HHSE managers and outside counsel are very confident will also be easily won or promptly resolved with no adverse affect to HHSE. Accordingly, the elimination of these legal matters will also improve the optics and credibility for HHSE,

5). WIDESPREAD SUPPLIER SUPPORT FOR MYFLIX - Like the opening day for the Oklahoma Land Rush, HHSE is at the starting line with our wagons loaded for a major digital stake into MYFLIX. The venture already has over 30 significant suppliers, including titles from three major studios, and potentially could be the # 2 streaming site in North America (subordinate only to Amazon.com) in terms of total quantity of features, television episodics, video games and educational programming. Titles that are currently "only" selling 5,000 DVDs suddenly become VERY PROFITABLE under the Myflix model, as there are no manufacturing or freight costs to dilute the revenue streams. Titles generating 5,000 TVOD transactions at $1.99 each (about $10,000) doesn't sound like a big deal... until you realize that Myflix now has access to over 10,000 titles and episodics. The potential revenues to be generated from this new streaming operation dwarfs even the best years ever achieved from the HHSE core activities with physical goods distribution.

6). TIMING IS IMMINENT: During the next few weeks, months and all occurring during this current fiscal year, HHSE believes that: a). Registration will occur; b). Myflix will be launched; c). New "whale" investor funds will begin accumulating shares; d). The new key-titles distribution pact through SONY and ongoing title releases through CINEDIGM will begin to monetize; e). The IRS Tax issue - the principal for which is now fully paid - will result in a formal "release of levy" filing; f). Production funding for two "event" level films will be finalized; and, g). HHSE's general credibility and financial position will dramatically increase.

It is for THESE KEY REASONS that HHSE managers have sought an opinion as to the legality and appopriateness for officers, directors and managers to buy HHSE shares off the open market at this time.

HHSE recognizes that there are currently some "bad optics" that the "bad-actor" traders have used to attempt to create fear and uncertainty. We feel the relentless (and false) criticisms against HHSE on stock chat boards by these trading manipulators has contributed to what is currently a "Black Friday" level of buying opportunities for HHSE shares. The motivation of these "bad actors" is to control the stock pricing and try to keep it trading at under $.015 for maximum swing on the "rinse-and-repeat" boxing strategy. But in doing so, they have taken our stock - which has been predicted by substantial investment funds to be worth ten-cents per share or more by year's end - and created a tremendous buying opportunity.

HHSE managers are seriously contemplating the prospect of buying shares at these current pricing levels, and wish to note to all legitimate shareholders that all of the information otherwise considered "inside" or "beneficial" towards supporting such an opinion, has been reiterated above. HHSE managers have NOT stalled on
the filing of the Form 10, or the resolution of legal matters, in order to fuel this unusual stock pricing opportunity. If HHSE managers proceed with purchases of HHSE shares off the open market at these current levels, the disclosure requirements of a Form 4 statement will be properly filed with the S.E.C. in a timely manner.





Hannover House Inc. (HHSE) Stock Research Links

HHSE Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Swanson Nexus Pro Launch: Boost for Dietitians

Updated Category News Views 38

Swanson Enters the Education Arena for Nutritionists Swanson Vitamins is mixing things up again! This time, they're launching something called Swanson Vitamins Nexus Pro, aimed squarely at the registered dietitians and licensed nutritionists crowd. Starting out as the place to grab your basic vitamins, Swanson's not resting on their supplement laurels. No, siree. They've...

Continue Reading
Medline's MedTrans Rodeo: Honoring Driver Excellence

Updated Category News Views 72

Rollin' Down the Road of Excellence In the world of healthcare logistics, Medline's MedTrans team isn't just steering trucks—they're steering safety culture and supply chain efficiency. This October, they wrapped up their fourth annual National Truck Rodeo in Mundelein, Illinois. And let me tell you, it was more than just a fancy event. It was about celebrating the real...

Continue Reading
Quest Diagnostics Faces Class Action After Data Breach

Updated Category News Views 4

Data Breach Rocks Quest Diagnostics October 2026 caught Quest Diagnostics in a bind they wish they could escape—a classic tech breach with personal info hanging out to dry. When a cyber ghost slipped into Quest's Quanum Lab Services Manager, it wasn't to deliver flowers. Nope, this unauthorized access was no friendly visit, forcing Quest to scream foul and play serious...

Continue Reading
Think Together Marks 20 Years of ASES Impact in CA

Updated Category News Views 77

Hands-on Learning: California's Bright Future Starts Here Who's ever thought a schoolyard's the same after three? Let me tell you, in California, it's staying alive and kicking, thanks to Think Together's whirlwind of celebrations for the After School Education and Safety (ASES) program. We're talking 450 schoolyard shindigs highlighting not just how far expanded learning...

Continue Reading
Bio-Thera's New Data: A Game Changer for NSCLC?

Updated Category News Views 146

A Fresh Look at Lung Cancer Solutions There's fresh meat on the oncology block, with Bio-Thera Solutions swinging for the fences at ESMO 2026, spotlighting promising Phase 2 clinical data for their combo treatment in first-line non-small cell lung cancer (NSCLC). If you're tuned into the biopharmaceutical sector or just keeping tabs on global health romps, this news sets...

Continue Reading
Alaska's Insurance Maze: Coverage Over Cheap Policies

Updated Category News Views 35

Beyond Premiums: Assessing Real Coverage Needs The Alaskan wilderness isn't just home to stunning views; it's also a land where insurance needs to go beyond the average cookie-cutter policy. You'd think the cheapest option would suffice, but that's where residents might trip into financial quicksand. Devery Prince, a seasoned insurance principal, sheds light on why...

Continue Reading
TORRAS Stands Tall with iPhone 18 Pro Cases

Updated Category News Views 150

TORRAS Shines in Magnetic Stand Case Evaluation In the whirlwind of smartphone accessories, where the battle lines are drawn between protection and functionality, TORRAS has emerged victorious with its magnetic stand cases for the iPhone 18 Pro and its beefier brother, the iPhone 18 Pro Max. Expert Consumers—a trusted name in product evaluations—has given TORRAS the...

Continue Reading
Galien Recognizes Kerry for Transformative Global Health Work

Updated Category News Views 75

Kerry's Legacy: A Symbol of Global Unity In the ever-thickening jungle of geopolitics and global health, it's rare to find a beacon as steadfast as John Kerry. This year, The Galien Foundation saw fit to honor him with the 2026 Roy Vagelos Pro Bono Humanum Award for Global Health Equity. This ain't just some shiny trinket—it’s a testament to his lifetime of ripping...

Continue Reading
PZZA Faces Class Action: Strategic Shake-up or Misstep?

Updated Category News Views 10

Papa John's: Doughy Deceit or Strategic Misfire? Once in a while, a corporation trips over its own ambitious production line, and Papa John’s (NASDAQ:PZZA) is the latest contestant to make headlines for all the wrong reasons. Investors in this pizza powerhouse are being called to the courtroom as a class action lawsuit unfolds, marking a turbulent stage in the...

Continue Reading
Monterey Desalination Project: Costs, Challenges & Future

Updated Category News Views 19

Water Woes Dragging on in Monterey? Alright, let's dive into the nitty-gritty of this water supply saga in the Monterey Peninsula. If you're wondering why California American Water is hustling so hard, it's because the taps around here ain't running like they should. This mess has been stretching on for ages, with everyone thirsty for a sustainable answer. The Cost of...

Continue Reading

Top 5 Most Recently Viewed Articles

Westland Insurance Celebrates Women's Soccer and NSL Final

Updated Category News Views 199

Westland Insurance Champions Women’s Soccer in Canada Westland Insurance is excited to announce its partnership with the Northern Super League (NSL), marking a significant step in supporting Canadian women's soccer. This three-year sponsorship is designed to enhance community connections while promoting the involvement of women in sports across the nation. Westland's...

Continue Reading
Understanding Unite Group plc's Public Opening Position Disclosure

Updated Category News Views 67

Public Opening Position Disclosure by Unite Group plc In the financial realm, transparency is key, and the public opening position disclosures play a significant role in ensuring this transparency. This document provides an essential overview of the position disclosure rules, particularly under Rule 8.3 of the Takeover Code, which pertains specifically to parties holding...

Continue Reading
OMNIQ's Strategic Changes Lead to Positive Financial Outcomes

Updated Category News Views 162

OMNIQ Enhances Financial Stability in 2025 OMNIQ Corp. (OTCMKTS:OMQS) has shown remarkable progress, marking a significant improvement in its financial performance. In a recent announcement, the company revealed a substantial reduction in net loss for the first half of 2025. The loss shrank to a mere $34,000, a staggering decrease from $5.1 million in the comparable...

Continue Reading
Anthropic's Revolutionary LLM: A New Era in AI Competition

Updated Category News Views 415

Anthropic's Latest AI Release: An Overview The landscape of artificial intelligence is increasingly competitive, with numerous companies striving to lead the charge in technology innovation. One of the key players, Anthropic, has recently unveiled its advanced language model, Claude 3.7 Sonnet. This model is being hailed as the most intelligent iteration to date,...

Continue Reading
Investors Unite: A Call for Engagement in Skye Bioscience Case

Updated Category News Views 123

Understanding the Class Action Opportunity with Skye Bioscience Many investors in Skye Bioscience, Inc. (NASDAQ: SKYE) have recently been alerted about a significant opportunity to participate in a class action lawsuit related to securities fraud. The firm guiding this initiative, Rosen Law Firm, is urging anyone who purchased shares between specific dates to come...

Continue Reading